ストックスクリーナーアプリを入手
161.28
1.89%
2.99
アフターアワーズ：
161.28
Insulet Corp (PODD) 最新ニュース
PODD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - GlobeNewswire Inc.
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
PODD Shareholder Alert: Insulet Corporation Securities - GlobeNewswire
Stifel cuts Insulet stock price target on valuation, keeps buy rating - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Insulet stock reflects steady diabetes tech demand as investors watch U.S. growth - AD HOC NEWS
Insulet (PODD) Stock Still Trades At A Premium As Shares Fell 47% - Yahoo Finance
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation LawsuitPODD - Morningstar
PODD Shareholder Alert: Insulet Corporation Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - Business Wire
Insulet focuses on diabetes technology growth. Business model supports recurring revenue - Ad-hoc-news.de
Levi & Korsinsky Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026PODD - Morningstar
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
PODD Maintained by Citigroup -- Price Target Raised to $172 - GuruFocus
Insulet (PODD) Launches Omnipod 5 In Spain, Is The Upside Already Priced In? - simplywall.st
Is Insulet Corporation (PODD) Stock Still a Diabetes Device Growth Opportunity After Analyst Target Cut? - Yahoo Finance
Insulet Broadens Omnipod 5 Presence With Commercial Launch in Spain - Yahoo Finance
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit - PR Newswire
Form 4 Insulet Corporation For: 7 July By Investing.com - Investing.com Nigeria
Insulet Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Insulet (PODD) director updates award to 151 deferred stock units - Stock Titan
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now? - Yahoo Finance
Why Insulet (PODD) Could Beat Earnings Estimates Again - Yahoo Finance
Insulet launches Omnipod 5 in Spain - MedTech Dive
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
PODD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - Morningstar
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
Insulet (PODD): Deutsche Bank Initiates Coverage With a Buy and a $190 Target - Insider Monkey
FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports - Benzinga
Class action lawsuit filed against Insulet over alleged false statements causing investor losses - Pluang
INSULET CORPORATION (PODD) INVESTOR ALERT Investors With - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm - Barchart.com
Insulet Misled Investors on Manufacturing Procedures, Suit Says - Bloomberg Law News
PODD Expands Omnipod 5 Launch to Spain, Enhancing Diabetes Care - GuruFocus
Insulet launches Omnipod 5 insulin system in Spain - Investing.com
Insulet launches Omnipod 5 insulin system in Spain By Investing.com - Investing.com South Africa
Insulet brings tubeless diabetes tech to Spain with Omnipod 5 launch - Stock Titan
VERI DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Veritone, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
PODDInsulet Corp Latest SEC Filings - Finviz
Rosen Law Firm Urges Insulet Corporation (NASDAQ: PODD) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Class action lawsuit filed against Insulet over alleged false statements on product safety. - Pluang
Bernstein SocGen cuts Insulet stock price target on valuation concerns - Investing.com
Insulet faces shareholder lawsuit over alleged false safety claims and product issues. - Pluang
Class action filed against Insulet over alleged product safety and disclosure issues, stock drops follow. - Pluang
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation - GlobeNewswire
Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD) - TMX Newsfile
FDA Alerts on Insulet (PODD) Device Safety Concerns - GuruFocus
Insulet (PODD) Faces Class I Recall of Omnipod Insulin Pump Syst - GuruFocus
Insulet Corporation: A High-Quality Growth Story Trading At A Reasonable PEG - Seeking Alpha
Class action lawsuit filed against Insulet over defective insulin delivery systems and stock drops. - Pluang
Insulet Investor Says Device Production Issues Tanked Stock - Law360
Insulet (PODD) director Jonathan Mazelsky receives initial 1,355-share RSU grant - Stock Titan
Insulet (NASDAQ: PODD) director files Form 3 showing no share holdings - Stock Titan
Insulet (PODD) director receives 144 deferred stock units as compensation - Stock Titan
Insulet will report Q2 results Aug. 5, with a call at 8 a.m. - Stock Titan
Insulet Corp (NASDAQ:PODD): Strong Growth Stock Consolidating Near Resistance for a Potential Breakout - ChartMill
A Look at Insulet Corp (PODD) After 3.5% Decline -- GF Value $39 - GuruFocus
Insulet Corporation's Stock Price Suffers a Dip to $152.25, Recording a 3.48% Drop: Market Analysis and Insights - Smartkarma
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines - Yahoo Finance
Could Insulet’s (PODD) Russell 2500 Debut Quietly Reframe the Omnipod Investment Narrative? - Yahoo Finance
2.36%
大文字化:
|
ボリューム (24 時間):